About Us
Recovering Hearts. Saving Lives.
Abiomed (NASDAQ: ABMD) is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support. The Impella® heart pump platform is designed to enable the heart to rest and recover by improving blood flow and/or temporarily assisting with the pumping function of the heart. The Abiomed Breethe OXY-1 System™ is designed to provide oxygenation while supporting patient mobility.

Our Leadership
Abiomed's board of directors and management team set our strategic direction. Learn more about our senior leadership.
Abiomed’s Four Principles
Commitment to Research
Abiomed invests in clinical research to provide the best possible outcomes for our patients.
Future Innovations
Through relentless innovation, we develop smaller, smarter, and more connected technology.

Our Story
Abiomed was founded in 1981 for the purpose of developing the world's first artificial heart. Explore this interactive timeline that shows how Abiomed’s mission evolved to focus on native heart recovery. Through its history, Abiomed has been dedicated to bringing the most advanced and innovative technology to patients and physicians.

Careers
We sustain a winning culture by putting patients first. We work collaboratively to foster a spirit of innovation. Our employees bring diverse ideas and experiences.
NPS-2554